Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Melanoma Brain Metastasis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01904123
What this trial is testing

STAT3 Inhibitor WP1066 in Treating Patients With Recurrent Malignant Glioma or Progressive Metastatic Melanoma in the Brain

Who this might be right for
Metastatic Malignant Neoplasm in the BrainMetastatic MelanomaRecurrent Brain Neoplasm+2 more
M.D. Anderson Cancer Center 8
Large-scale testing (Phase 3)Ended earlyNCT00020839
What this trial is testing

Temozolomide With or Without Radiation Therapy to the Brain in Treating Patients With Stage IV Melanoma That Is Metastatic to the Brain

Who this might be right for
Melanoma (Skin)Metastatic Cancer
European Organisation for Research and Treatment of Cancer - EORTC 23
Testing effectiveness (Phase 2)WithdrawnNCT02065466
What this trial is testing

Combo of Abraxane, TMZ, Bevacizumab in Metastatic Melanoma With Brain Metastases

Who this might be right for
Metastatic MelanomaBrain Metastases
University of Arizona
Testing effectiveness (Phase 2)Looking for participantsNCT03340129
What this trial is testing

Anti-PD 1 Brain Collaboration + Radiotherapy Extension (ABC-X Study)

Who this might be right for
Melanoma Stage Iv
Melanoma Institute Australia 218
Testing effectiveness (Phase 2)Looking for participantsNCT03563729
What this trial is testing

Melanoma Metastasized to the Brain and Steroids

Who this might be right for
Malignant Melanoma
Inge Marie Svane 80
Very early researchStudy completedNCT04752267
What this trial is testing

18F-FMAU PET/CT and MRI for the Detection of Brain Tumors in Patients With Brain Cancer or Brain Metastases

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Glioma+17 more
University of Southern California 10
Early research (Phase 1)Study completedNCT02716948
What this trial is testing

SRS and Nivolumab in Treating Patients With Newly Diagnosed Melanoma Metastases in the Brain or Spine

Who this might be right for
Metastatic Malignant Neoplasm in the BrainMetastatic Malignant Neoplasm in the SpineStage IV Skin Melanoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 17
Testing effectiveness (Phase 2)Study completedNCT00003308
What this trial is testing

Radiation Therapy in Treating Patients With Newly Diagnosed Brain Metastases From Kidney Cancer, Melanoma, or Sarcoma

Who this might be right for
Kidney CancerMelanoma (Skin)Metastatic Cancer+2 more
Eastern Cooperative Oncology Group
Testing effectiveness (Phase 2)Looking for participantsNCT05704647
What this trial is testing

Phase II Study of Nivolumab in Combination With Relatlimab in Patients With Active Melanoma Brain Metastases

Who this might be right for
Melanoma (Skin)
M.D. Anderson Cancer Center 30
Testing effectiveness (Phase 2)Ended earlyNCT04955743
What this trial is testing

Pembrolizumab and Lenvatinib in Patients With Brain Metastases From Melanoma or Renal Cell Carcinoma

Who this might be right for
MelanomaRenal Cell CarcinomaBrain Metastases+4 more
Yale University 18
Testing effectiveness (Phase 2)Study completedNCT02039947
What this trial is testing

Study to Evaluate Treatment of Dabrafenib Plus Trametinib in Subjects With BRAF Mutation-Positive Melanoma That Has Metastasized to the Brain

Who this might be right for
Melanoma and Brain Metastases
Novartis Pharmaceuticals 127
Testing effectiveness (Phase 2)Study completedNCT02978404
What this trial is testing

Combining Radiosurgery and Nivolumab in the Treatment of Brain Metastases

Who this might be right for
Clear-Cell Metastatic Renal Cell CarcinomaNon Small Cell Lung Cancer MetastaticBrain Metastases, Adult+2 more
Centre hospitalier de l'Université de Montréal (CHUM) 26
Testing effectiveness (Phase 2)Study completedNCT00623766
What this trial is testing

Evaluation of Tumor Response to Ipilimumab in the Treatment of Melanoma With Brain Metastases

Who this might be right for
Melanoma
Bristol-Myers Squibb 99
Not applicableActive Not RecruitingNCT03075072
What this trial is testing

Hippocampal Sparing Whole Brain Radiation Versus Stereotactic Radiation in Patients With 5-20 Brain Metastases: A Phase III, Randomized Trial

Who this might be right for
Brain Metastases
Dana-Farber Cancer Institute 196
Testing effectiveness (Phase 2)Study completedNCT01048554
What this trial is testing

Temozolomide Plus Bevacizumab in Patients With Metastatic Melanoma Involving the Central Nervous System

Who this might be right for
Melanoma
Mt. Sinai Medical Center, Miami 34
Not applicableEnded earlyNCT02700763
What this trial is testing

[18F]Dabrafenib Molecular Imaging in Melanoma Brain Metastasis

Who this might be right for
Melanoma
University Medical Center Groningen 1
Testing effectiveness (Phase 2)Study completedNCT02107755
What this trial is testing

Stereotactic Radiation Therapy and Ipilimumab in Treating Patients With Metastatic Melanoma

Who this might be right for
Liver MetastasesLung MetastasesRecurrent Melanoma+2 more
Ohio State University Comprehensive Cancer Center 8
Not applicableStudy completedNCT03520634
What this trial is testing

PD-L1 PET Imaging in Melanoma Patients

Who this might be right for
Melanoma
University Medical Center Groningen 10
Testing effectiveness (Phase 2)Looking for participantsNCT04511013
What this trial is testing

Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases

Who this might be right for
Acral Lentiginous MelanomaClinical Stage IV Cutaneous Melanoma AJCC v8Metastatic Cutaneous Melanoma+4 more
SWOG Cancer Research Network 112
Early research (Phase 1)Study completedNCT00539383
What this trial is testing

A Phase 1, Open-Label, Dose Escalation Study of ANG1005 in Patients With Advanced Solid Tumors and Metastatic Brain Cancer

Who this might be right for
Advanced Solid Tumors With and Without Brain Metastases
Angiochem Inc 56
Next Page